GlassScriptPhysician profile
Sarabjeet Suri
NPI 1174079404
$5,683.89
in general payments reported to CMS, 2019-2025
29 companies · $1,021 in 2025
The $1,021 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $564 · 2022: $2,605 · 2023: $769 · 2024: $725 · 2025: $1,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,305 · Education: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,304.59 |
| Education | $210.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,403.30 | 2022-2025 | Diamondback Coronary, Ensite, Ensite Precision |
| Terumo Medical Corporation | $562.11 | 2022-2025 | Glidewire, Metacross Otw, Angio-Seal |
| Boston Scientific Corporation | $314.59 | 2022-2025 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $280.99 | 2021-2025 | Farxiga, Wainua |
| Medtronic, INC. | $270.60 | 2021-2024 | Onyx Frontier, Symplicity G3, Aurora Ev-Icd Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $236.26 | 2021-2024 | Lifevest |
| Pfizer INC. | $233.79 | 2024-2025 | |
| Amgen INC. | $174.34 | 2022-2024 | Repatha |
| Cordis US Corp. | $141.31 | 2021 | |
| Cvrx, INC. | $138.74 | 2023 | Barostim Neo System |
| Shockwave Medical, INC | $109.99 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $105.53 | 2024-2025 | |
| Siemens Medical Solutions USA, INC. | $100.71 | 2025 | Acuson Origin Diagnostic Ultrasound System |
| Novo Nordisk INC | $79.54 | 2025 | Wegovy, Ozempic |
| Actelion Pharmaceuticals US, INC. | $65.07 | 2024 | Opsumit, Uptravi |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vital Connect, INC | $59.12 | 2025 | Vitalpatch Rtm |
| Angiodynamics, INC. | $58.53 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $43.78 | 2025 | Cobenfy |
| Heartflow, INC. | $42.28 | 2025 | |
| Glaxosmithkline, LLC. | $38.65 | 2025 | Shingrix, Arexvy |
| Chiesi USA, INC. | $37.01 | 2025 | Cleviprex, Kengreal |
| Janssen Pharmaceuticals, INC | $34.63 | 2023 | Xarelto |
| Merck Sharp & Dohme LLC | $30.59 | 2024 | Winrevair |
| W. L. Gore & Associates, INC. | $29.14 | 2021 | |
| Lantheus Medical Imaging, INC. | $25.86 | 2022 | |
| Teleflex LLC | $22.73 | 2023 | Turnpike |
| Thrombolex, INC. | $16.43 | 2025 | Bashir Endovascular Catheter |
| Edwards Lifesciences Corporation | $14.79 | 2024 | Hemosphere |
| Bridgebio Pharma, INC. | $13.48 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarabjeet Suri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.